Skip to main content

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.

Publication ,  Journal Article
Launonen, I-M; Lyytikäinen, N; Casado, J; Anttila, EA; Szabó, A; Haltia, U-M; Jacobson, CA; Lin, JR; Maliga, Z; Howitt, BE; Strickland, KC ...
Published in: Nat Commun
February 11, 2022

The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.

Duke Scholars

Published In

Nat Commun

DOI

EISSN

2041-1723

Publication Date

February 11, 2022

Volume

13

Issue

1

Start / End Page

835

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Proteomics
  • Prognosis
  • Ovarian Neoplasms
  • Mutation
  • Humans
  • Homologous Recombination
  • Genotype
  • Genes, BRCA2
  • Genes, BRCA1
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Launonen, I.-M., Lyytikäinen, N., Casado, J., Anttila, E. A., Szabó, A., Haltia, U.-M., … Färkkilä, A. (2022). Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun, 13(1), 835. https://doi.org/10.1038/s41467-022-28389-3
Launonen, I. -. M., N. Lyytikäinen, J. Casado, E. A. Anttila, A. Szabó, U. -. M. Haltia, C. A. Jacobson, et al. “Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.Nat Commun 13, no. 1 (February 11, 2022): 835. https://doi.org/10.1038/s41467-022-28389-3.
Launonen I-M, Lyytikäinen N, Casado J, Anttila EA, Szabó A, Haltia U-M, et al. Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022 Feb 11;13(1):835.
Launonen, I. .. M., et al. “Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.Nat Commun, vol. 13, no. 1, Feb. 2022, p. 835. Pubmed, doi:10.1038/s41467-022-28389-3.
Launonen I-M, Lyytikäinen N, Casado J, Anttila EA, Szabó A, Haltia U-M, Jacobson CA, Lin JR, Maliga Z, Howitt BE, Strickland KC, Santagata S, Elias K, D’Andrea AD, Konstantinopoulos PA, Sorger PK, Färkkilä A. Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022 Feb 11;13(1):835.

Published In

Nat Commun

DOI

EISSN

2041-1723

Publication Date

February 11, 2022

Volume

13

Issue

1

Start / End Page

835

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Proteomics
  • Prognosis
  • Ovarian Neoplasms
  • Mutation
  • Humans
  • Homologous Recombination
  • Genotype
  • Genes, BRCA2
  • Genes, BRCA1